Haschek H, Kärcher K H, Studler G
Wien Klin Wochenschr. 1984 Sep 14;96(17):642-6.
100 patients suffering from infiltrating urinary bladder cancer underwent transurethral resection followed by external megavolt irradiation (Betatron) are presented. The value of irradiation and its role in the actual therapeutic concept is discussed. The results of the combined therapy in infiltrative urinary bladder cancer using transurethral resection and megavolt irradiation are demonstrated according to stage (T2, T3) and histological grading (G2, G3). The 5-years survival rate amounts around 80%, in deep infiltrating bladder cancer about 50%. The morbidity of postoperative megavolt therapy was negligible. The results are superior to megavolt therapy alone and approach the one achieved by radical surgery; in addition the possibility of salvage-cystectomy remains open.
本文报告了100例浸润性膀胱癌患者，他们接受了经尿道切除术，随后进行了体外兆伏放疗（电子感应加速器）。讨论了放疗的价值及其在实际治疗理念中的作用。根据分期（T2、T3）和组织学分级（G2、G3）展示了经尿道切除术和兆伏放疗联合治疗浸润性膀胱癌的结果。5年生存率约为80%，深部浸润性膀胱癌约为50%。术后兆伏治疗的发病率可忽略不计。结果优于单纯兆伏治疗，接近根治性手术的效果；此外，挽救性膀胱切除术的可能性仍然存在。
